ArticlePharmaceutics2022

Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline.

Si Nga Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.